ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Orexigen Therapeutics, Inc. 

48 Wall Street
Suite 1100
New York  New York  10005  U.S.A.
Phone: 212-918-4650 Fax: 212-918-4801


SEARCH JOBS


Industry
Biotechnology






 Company News
Orexigen Therapeutics, Inc. (OREX) Reports Corporate And Financial Results For The Fourth Quarter And Year Ended December 31, 2013 3/13/2014 6:12:17 AM    More...
Orexigen Therapeutics, Inc. (OREX) To Host Full Year And Fourth Quarter 2013 Financial Results Conference Call And Webcast 3/3/2014 7:07:22 AM    More...
Orexigen Therapeutics, Inc. (OREX) To Present At The 34th Annual Cowen and Company Health Care Conference 2/27/2014 6:57:41 AM    More...
Orexigen Therapeutics, Inc. (OREX) To Present At Upcoming Investor Conferences 2/6/2014 6:47:05 AM    More...
Orexigen Therapeutics, Inc. (OREX) Announces June 10, 2014 PDUFA Action Date For Contrave 1/7/2014 6:48:04 AM    More...
Orexigen Therapeutics, Inc. (OREX) To Present At The J.P. Morgan 2014 Healthcare Conference 1/7/2014 6:20:58 AM    More...
Orexigen Therapeutics, Inc. (OREX) Resubmits Contrave New Drug Application 12/11/2013 9:53:38 AM    More...
Orexigen Therapeutics, Inc. (OREX) Announces The Closing Of Its Offering Of $115 Million Of Convertible Senior Notes 12/6/2013 9:30:29 AM    More...
Orexigen Therapeutics, Inc. (OREX) Prices Offering Of $100 Million Of Convertible Senior Notes 12/3/2013 11:29:44 AM    More...
Orexigen Therapeutics, Inc. (OREX) Offers $100 Million Of Convertible Senior Notes 12/3/2013 7:21:05 AM    More...
12345678910...